MADCAM1 and diabetes mellitus: Furthermore, NOD mice treated at an early age with an antibody blocking the mucosal addressin cell adhesion molecule-1 (MAdCAM-1) were almost completely protected from diabetes at 32-weeks old (9% diabetic compared to 80% in the control group) (92).